Peter Sporn MD FCCP, ATSF
Critical Care Medicine, Interstitial Lung Diseases
Professor of Medicine, Cell and Developmental Biology, and Medical Education, Feinberg School of Medicine, Northwestern University
Join to View Full Profile
Northwestern University Feinberg School of Medicine303 E. Superior St., SQBRC 5-302Chicago, IL 60611
Phone+1 312-908-8163
Fax+1 312-503-0411
Dr. Sporn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1984 - 1987
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Allergy and Immunology, 1983 - 1984
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1980 - 1983
- Wayne State University School of MedicineClass of 1980
Certifications & Licensure
- IL State Medical License 1991 - 2026
- MI State Medical License 1985 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Member, Pulmonary Disease Board American Board of Internal Medicine
- Regional Top Doctor Castle Connolly, 2005-2021
- Chair, Pulmonary Disease Exam Writing Committee American Board of Internal Medicine
- Join now to see all
Clinical Trials
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension Start of enrollment: 2008 Nov 01
- Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis Start of enrollment: 2019 Jan 29
- Routine Cardiac Screening in Sarcoidosis Patients Start of enrollment: 2019 Apr 05
- Join now to see all
Publications & Presentations
PubMed
- Retraction Note: Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-δ.Hanh Chi Do-Umehara, Cong Chen, Daniela Urich, Liang Zhou, Ju Qiu
Nature Immunology. 2025-02-01 - Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis.Ogugua Ndili Obi, Robert P Baughman, Elliott D Crouser, Mark W Julian, Landon W Locke
ERJ Open Research. 2025-01-01 - 1 citationsMyeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus.S Marina Casalino-Matsuda, Fei Chen, Francisco J Gonzalez-Gonzalez, Hiroaki Matsuda, Aisha Nair
JCI Insight. 2024-01-16
Press Mentions
- FSR Expands Scientific Advisory Board to Improve Research, CareSeptember 10th, 2024
Grant Support
- Clinical Studies NetworkFoundation for Sarcoidosis Research2018–2022
- Hypercapnia and Suppression of Antiviral Host DefenseNational Institutes of Health2017–2020
- Hypercapnia and Suppression of Antiviral Host DefenseNational Institutes of Health2016–2017
Committees
- Program Committee, Asthma, Allergy and Inflammation Assembly 2021 - Present
- Member, ABIM Pulmonary Disease Board 2020 - Present
- Chair, ABIM Pulmonary Disease Board Examination Writing Committee 2018 - Present
- Member, American Thoracic Society Scientific Advisory Committee 2018 - Present
- Member, Veterans Affairs Pulmonary Grant Review Panel 2018 - Present
- Member, ABIM Pulmonary Disease Board Examination Writing Committee 2010 - 2018
Professional Memberships
- Member
- World Association of Sarcoidosis and Other Granulomatous DisordersMember
- Americas Association of Sarcoidosis and Other DisordersMember
- Fellow
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: